Expert Radar
Dr. Vandana Abramson, MD, MSTR
Dr. Vandana Abramson, MD, MSTR
Leader, Vanderbilt Health (Nashville, TN)
Master of Science in Translational Research, University of Pennsylvania
Dr. Vandana G. Abramson has specialized experience in the field of Medical Oncology. They earned their BA in English and Molecular and Cellular Biology from the University of California, Berkeley, their MD from the University of Chicago Pritzker School of Medicine, and their MSTR from the University of Pennsylvania. After completing their residency in Medicine at Brigham and Women's Hospital, they went on to complete a fellowship in Hematology & Oncology at the Perelman School of Medicine at the University of Pennsylvania. Previously, they held roles as an Associate Professor at Vanderbilt University School of Medicine and Leader and Interim Co-Leader at Vanderbilt-Ingram Cancer Center. Currently, they work as a Physician at Vanderbilt Health, Co-Leader at Vanderbilt-Ingram Cancer Center, and Professor at the Vanderbilt University School of Medicine.
v*********@v****.org
(917) ***-****
Nashville, Tennessee
Get a FREE Demo of Dr. Vandana Abramson, MD, MSTR's Radar Profile
Review this expert's litigation history, supporting legal docs, publications, professional background, and more.
Comprehensive data on expert witnesses: Access detailed litigation history and performance metrics.
Swift assessment: Quickly evaluate an expert's track record.
Informed decisions: Make better choices when selecting or challenging expert witnesses in any case.
Radar Metrics At A Glance
Expert Witness Activity
Plaintiff Cases
Defense Cases
Expert Challenges
Deposition Transcripts
Publications
109
Media & News
728
Social Media Mentions
Expert Institute operates independently and objectively as an expert witness data provider. Expert Institute does not employ, endorse, or have an affiliation with any expert witnesses for which data is provided.
Expert Witness Activity
Case Name | Role | Filed Date |
|---|---|---|
James Archuleta, et al. v. Cibola General Hospital Co., et al. | Expert Witness | 2017-07-25 |
Vicki Chelli, et al. v. Louis M. Komer, et al. | Expert Witness | 2013-11-01 |
Radar monitors both national and state court systems to track litigation activity and access court documents.
View case details, documents, plaintiff and defense representation, defendants, judges, jurisdiction, and more.
Litigation Analytics
Retained By
Defense
Plaintiff
Activity over time
0
25
50
75
100
2000
0
2002
0
2004
0
2006
0
2008
0
2010
0
Activity by state
Case Outcome
0
25
50
75
100
Publications
Radar found 109 records
Title | Type |
|---|---|
A composite 18F-FDG PET/CT and HER2 tissue-based biomarker to predict response to neoadjuvant pertuzumab and trastuzumab in HER2-positive breast cancer (TBCRC026) | Journal Article |
Multiplex Spatial Proteomic Analysis of HER2-Positive Breast Tumors Reveals Unique Molecular and Immunologic Features Associated With Treatment Response | Journal Article |
Subcutaneous vs Intravenous Trastuzumab/Pertuzumab: A Time and Motion Substudy of a Phase II Trial of Adjuvant Trastuzumab/Pertuzumab for Stage i HER2+ Breast Cancer (ADEPT trial) | Journal Article |
Radar monitors a wide array of publication sources, including links to abstracts.
Review book chapters, journal articles, research papers, trade publications, technical reports, conference proceedings, and more.
Media & News
Radar found 728 records
Title | Description |
|---|---|
Nicole Kidman & Keith Urban 'love helping people' as they ... | Nov 19, 2024 ----- ... center , Vandana Abramson , MD, a Donna S. Hall Professor of Medicine and co - leader of the Breast Cancer Research Program at Vanderbilt - Ingram ... |
Chronic Hepatitis B: Chasing a Functional Cure - BreakingMED | Nov 8, 2024 ----- Reviewed By: Vandana G. Abramson , MD, Associate Professor of Medicine , Vanderbilt University Medical Center. CME/CE/ABIM MOC Information. More ... |
FDA expands approval of breast cancer drug Kisqali to ... | Sep 19, 2024 ----- Vandana Abramson who is the co-leader of the Breast Cancer Research Program at the Vanderbilt-Ingram Cancer Center in Nashville, Tennessee . |
Radar scours thousands of media and news sources across the internet 24/7.
Access interviews, webinars, TV appearances, blog posts, columns, whitepapers, PDFs, profressional profiles, and more.
Education
Institution | Degree Type |
|---|---|
University of Pennsylvania | Master of Science in Translational Research |
University of Chicago Pritzker School of Medicine | Doctor of Medicine |
University of California, Berkeley | Bachelor of Arts |
Work History
Title | Employer |
|---|---|
Leader | Vanderbilt Health (Nashville, TN) |
Physician | Vanderbilt Health (Nashville, TN) |
Interim Co-Leader | Vanderbilt-Ingram Cancer Center (Nashville, TN) |
What to expect from a Radar profile
Access detailed litigation history and performance metrics.
Access your Radar profile through Expert iQ, our secure, cloud-based platform that hosts AI-driven insights.
Delivered in 5–7 business days
Receive your profile swiftly, with Radar gathering intelligence from thousands of data points.
24/7 monitoring for 12 months
Stay informed with continuous monitoring and live alerts, ensuring your profile is always up-to-date.
